Bevacizumab: Difference between revisions
David Canner (talk | contribs) No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
< | <StructureSection load='' size='350' side='right' scene='Bevacizumab/Ba/1' caption='Model Bevacizumab, also known as Avastin"'> | ||
__TOC__ | |||
===Better Known as: Avastin=== | ===Better Known as: Avastin=== | ||
* Marketed By: Genentech & Roche<br /> | * Marketed By: Genentech & Roche<br /> | ||
Line 44: | Line 46: | ||
! 10 | ! 10 | ||
|} | |} | ||
</StructureSection> | |||
===References=== | ===References=== | ||
<references/> | <references/> | ||
__NOEDITSECTION__ | __NOEDITSECTION__ | ||
__NOTOC__ | __NOTOC__ |